Gaohua Han

1.0k total citations · 1 hit paper
39 papers, 637 citations indexed

About

Gaohua Han is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Gaohua Han has authored 39 papers receiving a total of 637 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 14 papers in Cancer Research and 13 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Gaohua Han's work include Cancer-related molecular mechanisms research (10 papers), RNA modifications and cancer (6 papers) and MicroRNA in disease regulation (4 papers). Gaohua Han is often cited by papers focused on Cancer-related molecular mechanisms research (10 papers), RNA modifications and cancer (6 papers) and MicroRNA in disease regulation (4 papers). Gaohua Han collaborates with scholars based in China, Romania and United States. Gaohua Han's co-authors include Junxing Huang, Wenhao Shen, Pei Pei, Shengbin Dai, Junmei Li, Teng Liu, Lin Hu, Kai Yang, Zhiyue Su and Wenhao Shen and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and ACS Nano.

In The Last Decade

Gaohua Han

34 papers receiving 631 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A Polymeric Hydrogel to Eliminate Programmed Death-Ligand 1 for Enhanced Tumor Radio-Immunotherapy

2023 122 citations Gaohua Han et al. profile →

Peers

Countries citing papers authored by Gaohua Han

Since Specialization

Citations

This map shows the geographic impact of Gaohua Han's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gaohua Han with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gaohua Han more than expected).

Fields of papers citing papers by Gaohua Han

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gaohua Han. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gaohua Han. The network helps show where Gaohua Han may publish in the future.

Co-authorship network of co-authors of Gaohua Han

This figure shows the co-authorship network connecting the top 25 collaborators of Gaohua Han. A scholar is included among the top collaborators of Gaohua Han based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gaohua Han. Gaohua Han is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Comparisons of blood, upper respiratory tract and gut viromes from patients with lung cancer and healthy persons 2025 ·International Journal of Cancer ·Li Wang, (unknown), (unknown), Xia Yang, Gaohua Han, (unknown), (unknown), Peng Lan, (unknown), Yue Chen, Youhua Xie, Juan Xu, Wen Zhang, Chenglin Zhou	0
2	A prospective, multicenter, comprehensive genomic profile signature study in patients with EGFR-mutant advanced non-small cell lung cancer at the first-line treatment failure of osimertinib 2025 ·Signal Transduction and Targeted Therapy ·Yuankai Shi, (unknown), (unknown), Chang Liu, (unknown), Yu Yan, (unknown), Xiubao Ren, (unknown), Gaohua Han, (unknown), (unknown), Jun Chen, Enguo Chen, (unknown), Yong Zhang	0
3	CRISPR/Cas9 library screening uncovered CCT2 as a critical driver of acquired resistance to EGFR-targeted therapy by stabilizing TMX1 in non-small cell lung cancer 2025 ·Cell Death and Differentiation ·(unknown), Qi Zhang, Xingyu Chen, Rongrong Jin, Gaohua Han, Qianhua Cao, Ke Zhu, Shihui Wei, (unknown), Qian Wang, Meiling Zhang, Weina Huang, Kaimin Li, (unknown), Kaihua Lu, Ying Chen, Chao Cao	0
4	RNA-binding motif protein 28 enhances angiogenesis by improving STAT3 translation in hepatocellular carcinoma 2024 ·Cancer Letters ·(unknown), (unknown), (unknown), Lei Liu, Hong‐Ren Yu, Gaohua Han, Qiang Wang, Mei Lin, Junxing Huang	2
5	Epithelial–Mesenchymal Transition in Non-Small Cell Lung Cancer Management: Opportunities and Challenges 2024 ·Biomolecules ·(unknown), Shanxun Yu, (unknown), Sihui Zhang, (unknown), Gaohua Han	3
6	Efficacy and safety of XELOX combined with anlotinib and penpulimab vs XELOX as an adjuvant therapy for ctDNA-positive gastric and gastroesophageal junction adenocarcinoma: a protocol for a randomized, controlled, multicenter phase II clinical trial (EXPLORING study) 2023 ·Frontiers in Immunology ·Yizhang Chen, Jiaguang Zhang, Gaohua Han, (unknown), (unknown), Wei Li, Li Xie, Hao Xu, Xinyi Zhang, (unknown), Lanlan Pan, Yongqian Shu, Ling Ma, Xiaofeng Chen	4
7	Diagnostic value of pleural fluid SMRP, CA125, MMP-7, and MMP-9 in malignant pleural effusion 2023 ·Medicine ·Gaohua Han, (unknown), (unknown), Ruyue Guo	1
8	Intramolecular fluorescence resonance energy transfer strategy for accurate detection of AFP-L3% and improved diagnosis of hepatocellular carcinoma 2023 ·Spectrochimica Acta Part A Molecular and Biomolecular Spectroscopy ·(unknown), Gaohua Han, (unknown), Xin Hua, Qian Zhu, Sisi Zhou, Ling Jiang, Quan Li, Songqin Liu	3
9	DNAAF5 promotes hepatocellular carcinoma malignant progression by recruiting USP39 to improve PFKL protein stability 2022 ·Frontiers in Oncology ·Yaping Liu, Qiong Wu, Tiantian Sun, (unknown), Gaohua Han, (unknown)	11
10	Long non-coding RNA LINC00511 facilitates colon cancer development through regulating microRNA-625-5p to target WEE1 2022 ·Cell Death Discovery ·(unknown), (unknown), (unknown), Gaohua Han, Ning Xu, Jun Ye, Ruixing Wang	12
11	Curcumin Mediates the Proliferation and Apoptosis of Colorectal Cancer Cells by Downregulating the Expression of Interleukin-1β through the Nuclear Factor-κB Signaling Pathway 2021 ·Pharmacognosy Magazine ·(unknown), (unknown), (unknown), Gaohua Han, Ruixing Wang, (unknown)	2
12	Thalidomide suppresses angiogenesis and immune evasion via lncRNA FGD5-AS1/miR-454–3p/ZEB1 axis-mediated VEGFA expression and PD-1/PD-L1 checkpoint in NSCLC 2021 ·Chemico-Biological Interactions ·Yang Xia, Weicheng Wang, Wenhao Shen, Kun Xu, Yangyang Hu, Gaohua Han, Yong-Biao Liu	40
13	Au-Pt Nanoparticle Formulation as a Radiosensitizer for Radiotherapy with Dual Effects 2021 ·International Journal of Nanomedicine ·Yang Song, Gaohua Han, Quansheng Chen, Lei Yu, Peng Wang, Qi Zhang, Jiang Xue Dong, Wei Zhang, Junxing Huang	53
14	Expression and Clinical Value of LncRNA GAPLINC in Esophageal Squamous Cell Carcinoma 2021 ·OncoTargets and Therapy ·Peng Wang, Yang Song, Shengbin Dai, Qingtao Ni, Huilan Liu, (unknown), (unknown), Gaohua Han, Junxing Huang	3
15	Assessment of the value of adjuvant radiotherapy for treatment of gastric adenocarcinoma based on pattern of post-surgical progression 2021 ·World Journal of Surgical Oncology ·Peng Wang, Hai‐Hua Zhou, Gaohua Han, Qingtao Ni, Shengbin Dai, Junxing Huang, Chunlei Dai, (unknown)	4
16	<p>Long Non-Coding RNA SPRY4-IT1 Reverses Cisplatin Resistance by Downregulating MPZL-1 via Suppressing EMT in NSCLC</p> 2020 ·OncoTargets and Therapy ·(unknown), Jingyao Gu, Pei Liu, Wang He, Lihua Jiang, Tianyao Lei, Shanxun Yu, Gaohua Han, Zhaoxia Wang	17
17	<p>Silencing lncRNA AFAP1-AS1 Inhibits the Progression of Esophageal Squamous Cell Carcinoma Cells via Regulating the miR-498/VEGFA Axis</p> 2020 ·Cancer Management and Research ·Wenhao Shen, (unknown), (unknown), Yang Song, Peng Wang, Gaohua Han, Bin Gu, Wei Zhang	13
18	<p>miRNA-181a-5p Enhances the Sensitivity of Cells to Cisplatin in Esophageal Adenocarcinoma by Targeting CBLB</p> 2020 ·Cancer Management and Research ·Yang Song, Peng Wang, Songhua Wang, (unknown), Qi Zhang, Wenhao Shen, Xiangyi Li, Wei Zhang, Gaohua Han	15
19	MicroRNA-140 Represses Esophageal Cancer Progression via Targeting ZEB2 to Regulate Wnt/β-Catenin Pathway 2020 ·Journal of Surgical Research ·Yang Song, Xiangyi Li, Wenhao Shen, Haitao Hu, Chen Li, Gaohua Han	30
20	Dose-escalated radiotherapy improved survival for esophageal cancer patients with a clinical complete response after standard-dose radiotherapy with concurrent chemotherapy 2018 ·Cancer Management and Research ·(unknown), Yijun Luo, Xiaoli Wang, Gaohua Han, Peng Wang, Wei Yuan, Shengbin Dai	15

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact